TOP HEADLINES:· A new trial conducted by AstraZenecaof 5,197 participants who had not been exposed to COVID-19showed a 77 percent reduced risk of developing symptomatic disease. The participants were
Simon Ormiston
Showing 0 to 17 of 1 results